Recent developments in the drug treatment of schizophrenia
- 1 February 1976
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 133 (2), 208-214
- https://doi.org/10.1176/ajp.133.2.208
Abstract
The author reviews six topics relevant to the drug treatment of schizophrenia. The quantitative effectiveness of promazine is of interest with respect to the structural models of the phenothiazines and the dopamine theory of schizophrenia. The quantitative effectiveness of antipsychotic drugs is also important in evaluating new agents and therefore relevant to a discussion of two newly released neuroleptics, molindone and loxapine. The author's discussion of high-dose treatment of typical acute schizophrenics or treatment-resistant patients reviews the available data and calls attention to the fact that these areas of pharmacologic research have not received sufficient attention.Keywords
This publication has 28 references indexed in Scilit:
- Drug and Sociotherapy in the Aftercare of Schizophrenic PatientsArchives of General Psychiatry, 1974
- Drug and Sociotherapy in the Aftercare of Schizophrenic PatientsArchives of General Psychiatry, 1973
- Chlorpromazine in Chronic SchizophreniaArchives of General Psychiatry, 1972
- Chlorpromazine Plasma Levels and EffectsArchives of General Psychiatry, 1970
- Factors Affecting Chlorpromazine Plasma Levels in Psychiatric PatientsArchives of General Psychiatry, 1970
- High Dose Chlorpromazine Therapy in Chronic SchizophreniaArchives of General Psychiatry, 1968
- Phenothiazines in Prevention of Psychiatric HospitalizationArchives of General Psychiatry, 1967
- Five Phenothiazine DerivativesArchives of General Psychiatry, 1961
- Drug Therapy in SchizophreniaJAMA Psychiatry, 1960
- Placebo ResponseArchives of Neurology & Psychiatry, 1957